MX2021011629A - Factor de proteccion contra la contaminacion de composiciones cosmeticas. - Google Patents
Factor de proteccion contra la contaminacion de composiciones cosmeticas.Info
- Publication number
- MX2021011629A MX2021011629A MX2021011629A MX2021011629A MX2021011629A MX 2021011629 A MX2021011629 A MX 2021011629A MX 2021011629 A MX2021011629 A MX 2021011629A MX 2021011629 A MX2021011629 A MX 2021011629A MX 2021011629 A MX2021011629 A MX 2021011629A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- type
- pollutant
- ppf
- ingredient
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 239000002537 cosmetic Substances 0.000 title abstract 5
- 239000003344 environmental pollutant Substances 0.000 abstract 5
- 231100000719 pollutant Toxicity 0.000 abstract 5
- 239000004615 ingredient Substances 0.000 abstract 4
- 238000010998 test method Methods 0.000 abstract 3
- 238000012360 testing method Methods 0.000 abstract 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 230000000475 sunscreen effect Effects 0.000 abstract 1
- 239000000516 sunscreening agent Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Computing Systems (AREA)
- Crystallography & Structural Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cosmetics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente invención se refiere a un método de determinación de un factor de protección contra la contaminación (PPF) de una composición cosmética, que comprende: (a) un paso de prueba, mediante cualquier método de prueba conocido, la capacidad (a) de la composición cosmética para hacer inefectivo al menos un tipo del contaminante presente en la piel y también lo expresa en una escala de 0 a 1, seguido de calcular dicho PPF por la ecuación A, donde (1-a) indica el daño residual potencial correspondiente a la piel en donde dicha composición comprende al menos un ingrediente conocido hacer inefectivo dicho al menos un tipo del contaminante y dicho al menos un ingrediente es un anti-inflamatorio o antioxidante; o alternativamente, (b) un paso de prueba, mediante cualquier método de prueba conocido, la capacidad (ß) de la composición cosmética para inhibir el contacto de al menos un tipo del contaminante con la piel y que también lo expresa en una escala de 0 a 1, seguido del cálculo de dicho PPF por la ecuación B, donde (1-ß) indica el daño residual potencial correspondiente a la piel en donde dicha composición comprende al menos un ingrediente que se sabe que inhibe el contacto de al menos un tipo del contaminante con la piel y en donde dicho ingrediente es un protector solar, un potenciador de barrera o un polímero; o además, alternativamente, (c) un paso de prueba, mediante cualquier método de prueba conocido, la capacidad (?) de la composición cosmética para eliminar al menos un tipo del contaminante presente en la piel, también lo expresa en una escala de 0 a 1, seguido del cálculo de dicho PPF por la ecuación C, donde (1-?) indica el daño residual potencial correspondiente a la piel.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019080317 | 2019-03-29 | ||
| EP19172948 | 2019-05-07 | ||
| PCT/EP2020/058246 WO2020200936A1 (en) | 2019-03-29 | 2020-03-25 | Pollution protection factor of cosmetic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021011629A true MX2021011629A (es) | 2022-10-05 |
Family
ID=69846147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021011629A MX2021011629A (es) | 2019-03-29 | 2020-03-25 | Factor de proteccion contra la contaminacion de composiciones cosmeticas. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220146499A1 (es) |
| EP (1) | EP3946005B1 (es) |
| CN (1) | CN113710146A (es) |
| MX (1) | MX2021011629A (es) |
| WO (1) | WO2020200936A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025098825A1 (en) * | 2023-11-09 | 2025-05-15 | Unilever Ip Holdings B.V. | A personal care composition and a method of treating skin |
| WO2025098792A1 (en) * | 2023-11-09 | 2025-05-15 | Unilever Ip Holdings B.V. | Use of a skin benefit agent in restoring skin's barrier function |
| WO2025098793A1 (en) * | 2023-11-09 | 2025-05-15 | Unilever Ip Holdings B.V. | Use of a skin benefit agent in boosting skin's night repair function |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0841952A1 (en) * | 1996-05-17 | 1998-05-20 | The University Of Sydney | A method of evaluating an effect of a substance applied to the skin of a mammal |
| KR100373519B1 (ko) | 2000-06-20 | 2003-02-25 | 주식회사 태평양 | 기후 인자들의 영향을 고려한 피부 오염 지수의 생성 방법 및 이를 이용한 피부 미용 정보 제공 방법 |
| DE102004020644A1 (de) * | 2004-04-22 | 2005-11-17 | Coty B.V. | Verfahren zur Bestimmung eines UVA- und UVB-Strahlung erfassenden integralen Sonnenschutzfaktors |
| EP1760440A1 (en) | 2005-08-31 | 2007-03-07 | The Procter and Gamble Company | Confocal raman spectroscopy for dermatological studies |
| US20080187502A1 (en) | 2007-02-02 | 2008-08-07 | Michelle Garay | Assessment and mitigation of oxidative stress in skin |
| CN101672787B (zh) * | 2009-03-16 | 2011-08-03 | 苏州博思维科生物科技研发中心有限公司 | 化妆品抗氧化能力的综合评价方法 |
| US10533992B2 (en) * | 2015-03-19 | 2020-01-14 | Amorepacific Corporation | Method for screening for sunlight protection functional material and method for evaluating sunlight protection effect |
| CN105675464A (zh) * | 2016-01-27 | 2016-06-15 | 曼秀雷敦(中国)药业有限公司 | 一种用于评价洗涤类化妆品抗污染功效的方法 |
| CN106442331B (zh) * | 2016-09-29 | 2021-02-26 | 上海家化联合股份有限公司 | 防晒产品防水能力的测试方法 |
| CN106290176A (zh) * | 2016-09-29 | 2017-01-04 | 上海家化联合股份有限公司 | 清洁类产品对附着于皮肤上的pm2.5清洁力的测试方法 |
| CN108785201B (zh) * | 2018-07-10 | 2021-04-06 | 广东芭薇生物科技股份有限公司 | 一种抗污染化妆品组合物及其应用的化妆品 |
-
2020
- 2020-03-25 MX MX2021011629A patent/MX2021011629A/es unknown
- 2020-03-25 WO PCT/EP2020/058246 patent/WO2020200936A1/en not_active Ceased
- 2020-03-25 CN CN202080026248.9A patent/CN113710146A/zh active Pending
- 2020-03-25 US US17/436,112 patent/US20220146499A1/en active Pending
- 2020-03-25 EP EP20712368.8A patent/EP3946005B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20220146499A1 (en) | 2022-05-12 |
| CN113710146A (zh) | 2021-11-26 |
| WO2020200936A1 (en) | 2020-10-08 |
| EP3946005A1 (en) | 2022-02-09 |
| EP3946005B1 (en) | 2022-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021011629A (es) | Factor de proteccion contra la contaminacion de composiciones cosmeticas. | |
| WO2011146491A3 (en) | Topical skin formulation | |
| MX389725B (es) | Seleccion de composiciones cosmeticas para camuflar imperfecciones tonales | |
| EP1906947A4 (en) | LIGHT-SENSITIVE COMPOSITION AND ITS USES | |
| McFadden et al. | Outbreak of methylisothiazolinone allergy targeting those aged≥ 40 years. | |
| HUP9800832A2 (hu) | Transzdermális formulált alak | |
| TW200833346A (en) | Liposome containing cardiolipin for improvement of mitochondrial function | |
| BR112012017443A2 (pt) | uso de copolímeros, método para aprimorar a resistência à água de uma formulação cosmética, formulação, e, composição de maquiagem para os olhos, os lábios ou a face | |
| CY1113585T1 (el) | Αντιρρυπαντικες συνθεσεις περιεχουσες σπινοσυνες, μεθοδοι χρησης αυτων και αντικειμενα προστατευμενα απο την προσκολληση βιορυπαντικων οργανισμων | |
| MX375149B (es) | Composición para el cuidado personal para un acondicionador, protector de color y polímero de modelado que comprende sustrato de queratina. | |
| EP4235121A3 (en) | System, apparatus and method for in situ polychromatic measurement of optical properties of topically applied sunscreen | |
| WO2019157181A3 (en) | Sunscreen composition | |
| DE50104383D1 (de) | Benzofuranonderivate enthaltende formulierung zum schutz vor oxidativem stress | |
| BR112018008335A2 (pt) | composição, e, método para umedecer, e proteger, reparar ou restaurar a barreira lipídica da pele. | |
| MX2020008168A (es) | Composiciones de polietileno. | |
| CO2020011989A1 (es) | Composición de protección solar pulverizable | |
| AR023690A1 (es) | Combinaciones de espesadores asociativos y composiciones acuosas para revestimientos protectores, uso de las mismas y producto revestido con dichacomposicion | |
| AR114722A1 (es) | Composiciones de erenumab y usos de las mismas | |
| FR3090383B1 (fr) | Composition comprenant un extrait de Lactobacillus rhamnosus | |
| AR120932A1 (es) | Composiciones de polietileno | |
| MX2022009293A (es) | Formulaciones de pantalla solar con oxido metalico. | |
| BR0105690A (pt) | Composições cosméticas contendo polìmero filmogênio, dispositivo aerossol, processo de manutenção ou de modelagem do penteado, processo de fabricação de polìmeros filmogênios, polìmero filmogênio e uso de uma composição | |
| EA199800589A1 (ru) | Применение экстрактов гинкго двудольного для получения фармацевтичиских композиций и способ косметической обработки с его использованием | |
| BR112023022697A2 (pt) | Fragrância para melhorar o estado de felicidade e método de avaliação | |
| BRPI0800123A (pt) | avaliação e mitigação de estresse oxidativo da pele |